A randomized study investigating the safety, tolerability, and pharmacokinetics of evinacumab, an ANGPTL3 inhibitor, in healthy Japanese and Caucasian subjects - Harada-Shiba, Mariko; Ali, Shazia; Gipe, Daniel A.; Gasparino, Evelyn; Son, Vladimir; Zhang, Yi; Pordy, Robert; Catapano, Alberico L. (Atherosclerosis, 2020)
Keywords: Angiopoietin-like protein 3; Cardiovascular disease; Clinical trial; Evinacumab; Homozygous familial hypercholesterolemia; Lipids and lipoprotein metabolism; Cardiovascular disease; Clinical trial; Lipids and lipoprotein metabolism; Homozygous familial hypercholesterolemia; Angiopoietin-like protein 3; Evinacumab